This content is from:Premium Tiger Cubs Poised to Benefit From This Covid-Related IPO AbCellera, which has developed a treatment for Covid-19, set terms this week for its IPO. ByStephen Taub December 08, 2020
This content is from:365亚博 Buyout Firms Take ‘Surprisingly Long’ to Exit Post-IPO Holdings — All While Raking in Fees Investors in private equity funds would have fared better under faster sell-down strategies, in terms of net and gross returns, a study found. By克里斯汀Idzelis February 01, 2021
This content is from:Premium These Companies Yielded a Big Payday for Viking Global Investors Two IPOs in which the Tiger Cub held sizable stakes surged in price, while another smaller biopharma stake has more than doubled since going public. ByStephen Taub December 14, 2020
This content is from:Premium An Under-the-Radar Hedge Fund Reaps Big IPO Rewards Bihua Chen’s Cormorant Asset Management is scoring big gains from development stage biopharma companies. ByStephen Taub December 17, 2020
This content is from:Premium Why Hedge Funds Love Health Care IPOs In recent months two companies with hedge fund ownership more than doubled, while several others are also up sharply. ByStephen Taub September 22, 2020
This content is from:Premium Tiger Global, Viking, Maverick Eye IPOs Citadel and Farallon are also gearing up for private holdings going public. ByStephen Taub November 24, 2020
